Login / Signup
PD-L1: an unavoidable biomarker in advanced triple-negative breast cancer.
Mira Akiki
Fady Gh Haddad
Hampig Raphael Kourie
Abir Khaddage
Viviane Track Smayra
Published in:
Biomarkers in medicine (2019)
Keyphrases
</>